Market Overview

Actavis plc Buying Allergan In $66 Billion Deal

Yourent Takes Direct Aim At The Hotel Industry
25 Stocks Moving In Monday's Pre-Market Session

Actavis plc (NYSE: ACT) is acquiring Allergan, Inc. (NYSE: AGN) for $66 billion or $129 per share, thus avoiding being acquired by Valeant and Pershing Square, according to CNBC's David Faber.

Valeant has said it cannot justify paying that price. This likely ends the ongoing sage between Bill Ackman of Pershing Square and Allergan.

Shares of Allergan were trading higher by 7 percent at $212.70, while shares of Actavis were higher by 3.7 percent at $252.80.

Posted-In: CNBC News M&A Media


Related Articles (AGN + ACT)

View Comments and Join the Discussion!